Private companies based in Quebec with life sciences-related activities are invited to offer two 6-month post-diploma internship positions for new graduates (Masters and PhD), future awardees of the Gordon Shore Prize. The Funders of this award, CQDM, Diazon, the Oncopole and Mitacs will finance 50 % of these post-diploma internships. The company must agree to…
Montreal, Quebec – November 19, 2018 – CQDM is delighted to announce that Merck Canada, a founding member of the consortium, is renewing its commitment with a $3.5M contribution to support the development of disruptive technologies in biopharmaceutical research in Quebec and Canada. The research and development projects funded as part of this initiative will…
A first project led by Professor Brian Chen at the Research Institute of the McGill University Health Centre is selected for funding thanks to the Pfizer contribution Montreal, November 19, 2018 – We are pleased to announce that Pfizer Canada, a founding member of CQDM, renews its confidence in CQDM with a contribution of $550,000.…
Montreal, November 19th 2018 – CQDM is pleased to welcome Amgen as a new member of its biopharmaceutical research consortium established to identify and invest in highly innovative biopharmaceutical research projects in Quebec and Canada with the ultimate goal of enabling the development of better treatments for patients. This announcement was made at CQDM’s 10th…
Montreal, November 19, 2018 – CQDM, Diazon and the Oncopole, in collaboration with Mitacs, are pleased to announce the creation of the Gordon Shore Prize to pay tribute to the remarkable accomplishments of Professor Shore in the field of cancer research. CQDM, Diazon, the Oncopole, in collaboration with Mitacs, will endow the newly founded Gordon…
Montreal, October 19, 2018 – The sector-based industrial research clusters (RSRI) congratulate the new Minister of the Economy and Innovation, Mr. Pierre Fitzgibbon, and assure him and the entire government of their full and active collaboration to stimulate the link between academic research and innovative businesses in Quebec. Representing Quebec’s flagship sectors, the RSRIs are…
Zoic Capital, Desjardins Capital and Other Investors Join Montréal-based Alzheimer Early Detection Optina Diagnostics $4 M Seed Round Montréal, Québec, Oct. 10, 2018—Optina Diagnostics Inc., a leader in early detection of Alzheimer through the use of Artificial Intelligence (AI) and Spectral Retinal Imaging, has raised C$4 million in a new round of funding to scale…
The 29th Life Sciences Success Conference “Inspiring Success Series: Optel, technologies for a better world” will take place on October 10, 2018. It’s an information session on funding programs in Life Sciences and Health Technologies. CQDM will present these funding programs. You can access conference details by clicking here. LIFE SCIENCES CONFERENCEWEDNESDAY, OCTOBER 10, 2018Optel…
About CQDM CQDM is a not-for-profit pharma-based consortium active in biopharmaceutical research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM’s business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research and benefit from its results.…
As part of its SynergiQc program and in addition to its regular and ongoing call for proposals, CQDM is pleased to inform the Quebec research community of the launch of a targeted Call for Proposals focused on breast cancer research. Thanks to a partnership established with the Canadian Cancer Society, up to $5M will be…